Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
📧 Sign up to get email alerts when something new happens for Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]
Phase 3 trial comparing ranibizumab 0.5 mg to verteporfin PDT for visual impairment from CNV due to pathologic myopia; study completed with …